A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

Volume 19, 2015 Articles
Title/Author (Click for Abstract / Details / Purchase)	Issue/​Page View/Buy
PreScription: 2014 in Review Allen Loyd V Jr	Jan/Feb 2015 Pg. 4
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jan/Feb 2015 Pg. 6-12
Giving Back: A Win-Win Plan of Action for Compounding Pharmacists Rudner Shara	Jan/Feb 2015 Pg. 14-17
Pharmacy Student Survey: Perceptions and Expectations of Pharmaceutical Compounding Carvalho Maria, Batra Bindhu	Jan/Feb 2015 Pg. 18-27
Agar Transfer Devices for Environmental Sampling in the Compounding Pharmacy: Science and Compliance Grilli Anthony, Sutton Scott	Jan/Feb 2015 Pg. 30-37
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1 Allen Loyd V Jr	Jan/Feb 2015 Pg. 38-40
Quality Control Analytical Methods: Refractive Index Allen Loyd V Jr	Jan/Feb 2015 Pg. 43-47
Basics of Sterile Compounding: Aseptic Processing Akers Michael J	Jan/Feb 2015 Pg. 49-56
Basics of Compounding: The Revised "Not to Compound List" Allen Loyd V Jr	Jan/Feb 2015 Pg. 57-58
Calculations Stockton Shelly J	Jan/Feb 2015 Pg. 59
Atenolol 25-, 50-, or 100-mg Capsules Allen Loyd V Jr	Jan/Feb 2015 Pg. 60
Azathioprine 50-mg Capsules Allen Loyd V Jr	Jan/Feb 2015 Pg. 61
Cisplatin 1-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 62
Daunorubicin 5-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 63
Erythromycin 50-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 64
Hydralazine Hydrochloride 20-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 65
Hydroxychloroquine Sulfate 200-mg Capsules Allen Loyd V Jr	Jan/Feb 2015 Pg. 66
Lidocaine Hydrochloride 4% Topical Solution Allen Loyd V Jr	Jan/Feb 2015 Pg. 67
Mupirocin 2% Ointment Allen Loyd V Jr	Jan/Feb 2015 Pg. 68
Phentolamine Mesylate 5-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 69
Stability Assessment of Repackaged Bevacizumab for Intravitreal Administration Pereboom Marieke, Becker Matthijs L, Amenchar Mostapha, Verweij Sjoerd L, van der Hoeven Ruud TM, Mulder Inge J	Jan/Feb 2015 Pg. 70-72
Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica	Jan/Feb 2015 Pg. 73-77
Stability of Suspensions: Theoretical and Practical Considerations before Compounding Hadziabdic Jasmina, Elezovic Alisa, Rahic Ognjenka, Mujezin Indira, Vranic Edina	Jan/Feb 2015 Pg. 78-85
PostScription: Pharmacists Advancing Toward Provider Status Menighan Thomas E	Jan/Feb 2015 Pg. 86-87
PreScription: Some of the Best Sermons are Lived, not Preached! Allen Loyd V Jr	Mar/Apr 2015 Pg. 92
New England Compounding Center Indictment Cabaleiro Joe	Mar/Apr 2015 Pg. 94-102
Standing Together Fixing the Drug Quality and Security Act Miller David G	Mar/Apr 2015 Pg. 104-106
Standarized Compounding: The Importance of Doing it the Same Way Every Time Dillon L Rad	Mar/Apr 2015 Pg. 109-112
Bedside Manner: Not Just for Doctors Anymore Cormier Mindy	Mar/Apr 2015 Pg. 115-118
Quality Assurance and Quality Control, Part 1 Akers Michael J	Mar/Apr 2015 Pg. 121-124
Basics of Sterile Compounding: Sterilization Methods in Sterile Product Manufacturing Akers Michael J	Mar/Apr 2015 Pg. 127-138
Calculations Stockton Shelly J	Mar/Apr 2015 Pg. 140-141
Acne Scrub Allen Loyd V Jr	Mar/Apr 2015 Pg. 142
Aminohippurate Sodium 200-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 143
Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 144
Heparin 335-United/Gram Gel-Cream Allen Loyd V Jr	Mar/Apr 2015 Pg. 145
L-Cysteine Hydrochloride 50-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 146
Morrhuate Sodium 5% Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 147
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution Allen Loyd V Jr	Mar/Apr 2015 Pg. 148
Pancuronium Bromide 1-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 149
Physostigmine Salicylate 1-mg/mL Injection Allen Loyd V Jr	Mar/Apr 2015 Pg. 150
Trypan Blue 0.06% Ophthalmic Solution Allen Loyd V Jr	Mar/Apr 2015 Pg. 151
Transdermal Delivery of Nisoldipine: Refinement of Vehicles El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A	Mar/Apr 2015 Pg. 152-160
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott	Mar/Apr 2015 Pg. 161-166
Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott	Mar/Apr 2015 Pg. 167-173
PostScription: What's Your Patient Care Story? Menighan Thomas E	Mar/Apr 2015 Pg. 174-175
PreScription: 2015 Student Pharmacist Compounding Competition Allen Loyd V Jr	May/Jun 2015 Pg. 180
Dry-heat Depyrogenation Ovens for Pharmaceutical Compounding Facilities Weller Tom, Kragseth Rolf, Dullinger Roger, Illum Henrik, Perry Alan	May/Jun 2015 Pg. 182-192
Compounded Testosterone Troches to optimize Health and the Testosterone Controversy Guth Michael AS	May/Jun 2015 Pg. 195-203
Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls Gonzalez Mark	May/Jun 2015 Pg. 205-211
IACP Says: "Fix DQSA" Miller David	May/Jun 2015 Pg. 212
Quality Assurance and Quality Control, Part 2 Akers Michael J	May/Jun 2015 Pg. 215-221
Basics of Compounding: Compounding with Silicones Allen Loyd V Jr	May/Jun 2015 Pg. 223-230
Basics of Sterile Compounding: Contamination Control Akers Michael J	May/Jun 2015 Pg. 232-238
Calculations Stockton Shelly J, Saluja Hardeep Singh	May/Jun 2015 Pg. 240-241
Atropine Sulfate 1% Ophthalmic Solution Allen Loyd V Jr	May/Jun 2015 Pg. 242
Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Allen Loyd V Jr	May/Jun 2015 Pg. 243
Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches Allen Loyd V Jr	May/Jun 2015 Pg. 244
Phenazopyridine Hydrochloride 200-mg Capsules Allen Loyd V Jr	May/Jun 2015 Pg. 245
Physostigmine Salicylate 1-mg/mL Injection Allen Loyd V Jr	May/Jun 2015 Pg. 246
Scopolamine Hydrobromide -.4-mg/mL Injection Allen Loyd V Jr	May/Jun 2015 Pg. 247
Stability of Metronidazole Suspensions Donnelly Ronald F, Ying James	May/Jun 2015 Pg. 248-251
Protocol of Blood Serum Eye Drops Katsakoulas Ioannis, Lougovoi Claudia, Paraskevopoulou Penelope, Vougioukas Nikolaos	May/Jun 2015 Pg. 252-260
Physico-chemical Stability of MabThera Drug-product Solution for Subcutaneous Injection under In-use Conditions with Different Administration Materials Mueller Claudia, Dietel Elde, Heynen Severin R, Nalenz Heiko, Goldbach Pierre, Mahler Hanns-Christian, Schmidt Johannes, Grauschopf Ulla, Schoenhammer Karin	May/Jun 2015 Pg. 261-267
Long-term Stability of Cocaine Hydrochloride Aqueous Solution 50 mg/mL (5%) at Room Temperature and at 5°C ± 3°C in Glass Bottles Dewulf Joseph, Hecq Jean-Daniel, Huvelle Sophie, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M	May/Jun 2015 Pg. 268-270
PostScription: Opportunities to Change the Pharmacy Landscape Menighan Thomas E	May/Jun 2015 Pg. 271
PreScription: Potpourri of Opinions…From Many Allen Loyd V	Jul/Aug 2015 Pg. 266
Safer Sterile Compounding: Choosing and Using Disinfectants for the Cleanroom Kastango Eric S, Douglass Kate, Patel Kedar, Givehchi Babak, Brister Paul, Postlewaite Jay, Taraban Laura	Jul/Aug 2015 Pg. 268-278
Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 2 Allen Loyd V	Jul/Aug 2015 Pg. 280-287
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Biundo Bruce, Gogola Margaret	Jul/Aug 2015 Pg. 289-293
Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi	Jul/Aug 2015 Pg. 295-300
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
Quality Control Analytical Methods: Physical Quantitative Verification of Nonsterile Compounded Preparations: Individualized Dosage Units Sidhu Raman	Jul/Aug 2015 Pg. 307-310
Basics of Compounding: The "Negative" List Allen Loyd V	Jul/Aug 2015 Pg. 311-313
Basics of Sterile Compounding: Barrier Isolator Technologist in Aseptic Processing Akers Michael J	Jul/Aug 2015 Pg. 315-320
Calculations Stockton Shelly J	Jul/Aug 2015 Pg. 322
Ammonium Molybdate 25-mcg/mL Injection Allen Loyd V	Jul/Aug 2015 Pg. 324
Balsam Peru, Castor Oil, and Trypsin Ointment Allen Loyd V	Jul/Aug 2015 Pg. 325
Benzonatate 100-mg Capsules Allen Loyd V	Jul/Aug 2015 Pg. 326
Chloroquine Phosphate 250-mg Capsules Allen Loyd V	Jul/Aug 2015 Pg. 327
Cytarabine 50-mg/mL Injection Allen Loyd V	Jul/Aug 2015 Pg. 328
Moxifloxacin Hydrochloride 1.6-mg/mL Intravenous Injection Allen Loyd V	Jul/Aug 2015 Pg. 329
Oxytocin 10-units/mL Injection Allen Loyd V	Jul/Aug 2015 Pg. 330
Phytonadione 2-mg/mL Injection Allen Loyd V	Jul/Aug 2015 Pg. 331
Proparacaine Hydrochloride 0.5% Ophthalmic Solution Allen Loyd V	Jul/Aug 2015 Pg. 332
Tacrolimus Capsules, 0.5 mg, 1 mg, or 5 mg Allen Loyd V	Jul/Aug 2015 Pg. 333
Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters Puertos Enrique, Spencer Melissa	Jul/Aug 2015 Pg. 334-336
Stability of Prednisone in Oral Mix Suspending Vehicle Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim	Jul/Aug 2015 Pg. 337-339
Development and Validation of an Inexpensive, Simple, and Rapid Technique for Measuring the Accuracy of Extemporaneously Compounded Pharmaceuticals Meek Claudia, Rothardt Andrew, Evans Jason, Thurman Rosanne, Ashworth Lisa, Leff Richard	Jul/Aug 2015 Pg. 340-343
Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Anderson Collin R, Halford Zachery, MacKay Mark	Jul/Aug 2015 Pg. 344-347
PostScription: APhA2015: You Spoke, We Listened, and What a Success! Menighan Thomas E	Jul/Aug 2015 Pg. 348-349
PreScription: Failure or Success? Allen Loyd V Jr	Sep/Oct 2015 Pg. 354
Novel Approaches to Topical Psoriasis Therapy Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin	Sep/Oct 2015 Pg. 357-365
Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Guth Michael AS	Sep/Oct 2015 Pg. 367-373
The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding Miller David G	Sep/Oct 2015 Pg. 375
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake	Sep/Oct 2015 Pg. 377-380
Using Hospital Laboratory Services to Perform Quality-control Testing on Compounded Preparations Donnelly Ronald F	Sep/Oct 2015 Pg. 383-386
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr	Sep/Oct 2015 Pg. 389-390
Sterile Filtration Akers Michael J	Sep/Oct 2015 Pg. 393-401
Calculations Stockton Shelly J, Saluja Hardeep Singh	Sep/Oct 2015 Pg. 402
Aminocaproic Acid 250-mg/mL Oral Solution Allen Loyd V Jr	Sep/Oct 2015 Pg. 404
Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel Allen Loyd V Jr	Sep/Oct 2015 Pg. 405
Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment Allen Loyd V Jr	Sep/Oct 2015 Pg. 406
Nimodipine 3-mg/mL Oral Solution Allen Loyd V Jr	Sep/Oct 2015 Pg. 407
Ofloxacin 0.3% Otic Solution Allen Loyd V Jr	Sep/Oct 2015 Pg. 408
Povidone Iodine 10% Cold Sore Paint Allen Loyd V Jr	Sep/Oct 2015 Pg. 409
Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion Allen Loyd V Jr	Sep/Oct 2015 Pg. 410
Vehicle for Oral Solution (National Formulary 26) Allen Loyd V Jr	Sep/Oct 2015 Pg. 411
Vehicle for Oral Solution, Sugar Free (National Formulary 26) Allen Loyd V Jr	Sep/Oct 2015 Pg. 412
Vehicle for Oral Suspension (National Formulary 26) Allen Loyd V Jr	Sep/Oct 2015 Pg. 413
Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa	Sep/Oct 2015 Pg. 414-419
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Geiger Christine M, Sorenson Bridget, Whaley Paul	Sep/Oct 2015 Pg. 420-427
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures Nahata Milap C	Sep/Oct 2015 Pg. 428-431
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers Bhattacharya Sisir, Parekh Satish, Dedhiya Mahendra	Sep/Oct 2015 Pg. 432-436
PostScription: Progress Report: Provider Status Continues to Gain Strength! Menighan Thomas E	Sep/Oct 2015 Pg. 437
PreScription: The Documented Past and the Exciting Future Allen Loyd V Jr	Nov/Dec 2015 Pg. 442
Clinical Perspectives in Compounding: Compounding Gains and Losses Since I Met "Careless Arithmetic Nullifies Careful Compounding" Newton David W	Nov/Dec 2015 Pg. 444-446
International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance Miller David G	Nov/Dec 2015 Pg. 449-450
Applying Quality of Design Concepts to Pharmacy Compounding Timko Robert J	Nov/Dec 2015 Pg. 453-463
Root Cause Analysis, Part 1: Nonsterile Compounding Cabaleiro Joe, Jackson Kathleen	Nov/Dec 2015 Pg. 465-469
Basic Principles of Lyophilization, Part 1 Akers Michael J	Nov/Dec 2015 Pg. 471-476
Mixing in a Compounding Pharmacy in the 21st Century Standridge Rob	Nov/Dec 2015 Pg. 479-484
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems Akers Michael J	Nov/Dec 2015 Pg. 491-500
Calculations Stockton Shelly J	Nov/Dec 2015 Pg. 502
Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules Allen Loyd V Jr	Nov/Dec 2015 Pg. 504
Cefepime Hydrochloride 100-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2015 Pg. 505
Cefotaxime 100-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2015 Pg. 506
Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Allen Loyd V Jr	Nov/Dec 2015 Pg. 507
Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Allen Loyd V Jr	Nov/Dec 2015 Pg. 508
Estradiol Valerate 40-mg/mL in Oil Injection Allen Loyd V Jr	Nov/Dec 2015 Pg. 509
Levetiracetam 100-mg/mL Injection (Concentrate) Allen Loyd V Jr	Nov/Dec 2015 Pg. 510
Memantine Hydrochloride Capsules Allen Loyd V Jr	Nov/Dec 2015 Pg. 511
Mupirocin 2% Nasal Ointment Allen Loyd V Jr	Nov/Dec 2015 Pg. 512
Propranolol Hydrochloride Capsules Allen Loyd V Jr	Nov/Dec 2015 Pg. 513
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Lobb William B, Wilkin Noel E, Holmes Erin R	Nov/Dec 2015 Pg. 514-520
Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5°C ± 3°C after Microwave Freeze-thaw Treatment Hecq Jean-Daniel, Rolin Catherine, Godet Marie, Gillet Patricia, Jamart Jacques, Galanti Laurence M	Nov/Dec 2015 Pg. 521-524
PostScription: Pharmacy Fellowship Program: Building a Stronger Profession Bernardi Steve	Nov/Dec 2015 Pg. 525
Return to Top